Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sarepta Therapeutics Inc shares valued at $508,900 were sold by Murray Dallan on May 02 ’24. At $140.00 per share, Murray Dallan sold 3,635 shares. The insider’s holdings dropped to 18,125 shares worth approximately $2.3 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Boor Kathryn Jean sold 761 shares, netting a total of over 93,550 in proceeds. Following the sale of shares at $122.93 each, the insider now holds 7,516 shares.
Before that, Wigzell Hans Lennart Rudolf had sold 15,000 shares from its account. In a trade valued at $1,848,795, the Director traded Sarepta Therapeutics Inc shares for $123.25 each. Upon closing the transaction, the insider’s holdings decreased to 15,000 shares, worth approximately $2.9 million.
As published in a research note from Oppenheimer on May 14, 2024, Sarepta Therapeutics Inc [SRPT] has been rated up from a Perform to an Outperform and the price target has been revised to $180. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in late January. Earlier on December 12, 2023, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for SRPT stock.
Analyzing SRPT Stock Performance
During the last five days, there has been a drop of approximately -4.23%. Over the course of the year, Sarepta Therapeutics Inc shares have jumped approximately 31.84%. Shares of the company reached a 52-week high of $146.68 on 05/07/24 and a 52-week low of $91.34 on 01/05/24. A 50-day SMA is recorded $126.91, while a 200-day SMA reached $114.04. Nevertheless, trading volume fell to 0.85 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Sarepta Therapeutics Inc (SRPT)
According to the 24-hour chart, there is a support level at 125.14, which, if violated, would cause prices to drop to 123.15. In the upper region, resistance lies at 129.48. The next price resistance is at 131.83. RSI (Relative Strength Index) is 44.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.54, which suggests the price will decrease in the coming days. Percent R is at 92.30%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
